(Q30889969)

27 June 2017

1 reference

title

In vivo amyloid imaging in Alzheimer's disease (English)

1 reference

27 June 2017

0 references

0 references

Sair HI

1

1 reference

27 June 2017

Doraiswamy PM

series ordinal

2

1 reference

27 June 2017

Petrella JR

series ordinal

3

1 reference

27 June 2017

publication date

23 January 2004

1 reference

27 June 2017

1 reference

27 June 2017

volume

46

1 reference

27 June 2017

issue

2

1 reference

27 June 2017

page(s)

93-104

1 reference

https://scigraph.springernature.com/pub.10.1007/s00234-003-1034-9

27 June 2017

exact match

0 references

cites work

Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease

1 reference

12 December 2020

Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide

1 reference

12 December 2020

Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure

1 reference

12 December 2020

The cause of neuronal degeneration in Alzheimer's disease

1 reference

12 December 2020

The origins of Alzheimer disease: a is for amyloid.

1 reference

12 December 2020

Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease

1 reference

12 December 2020

Quantifying amyloid beta-peptide (Abeta) aggregation using the Congo red-Abeta (CR-abeta) spectrophotometric assay.

1 reference

12 December 2020

Prospects for noninvasive imaging of brain amyloid beta in Alzheimer's disease.

1 reference

12 December 2020

Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

12 December 2020

Neuropathological diagnosis of Alzheimer's disease: a perspective from longitudinal clinicopathological studies

1 reference

12 December 2020

Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective.

1 reference

12 December 2020

IBOX(2-(4'-dimethylaminophenyl)-6-iodobenzoxazole): a ligand for imaging amyloid plaques in the brain

1 reference

12 December 2020

Development of an anti-A beta monoclonal antibody for in vivo imaging of amyloid angiopathy in Alzheimer's disease.

1 reference

12 December 2020

99mTc-MAMA-chrysamine G, a probe for beta-amyloid protein of Alzheimer's disease

1 reference

12 December 2020

CNS drug design based on principles of blood-brain barrier transport

1 reference

12 December 2020

Neuroimaging of vessel amyloid in Alzheimer's disease.

1 reference

12 December 2020

Synthesis and amyloid binding properties of rhenium complexes: preliminary progress toward a reagent for SPECT imaging of Alzheimer's disease brain

1 reference

12 December 2020

Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease.

1 reference

12 December 2020

Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex

1 reference

12 December 2020

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

1 reference

12 December 2020

Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease

1 reference

12 December 2020

Chrysamine-G binding to Alzheimer and control brain: autopsy study of a new amyloid probe

1 reference

12 December 2020

Concentration of serum amyloid P component in the CSF as a possible marker of cerebral amyloid deposits in Alzheimer's disease.

1 reference

12 December 2020

Development of a monoclonal antibody specific for beta/A4 amyloid in Alzheimer's disease brain for application to in vivo imaging of amyloid angiopathy

1 reference

12 December 2020

Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau.

1 reference

12 December 2020

Scintigraphy with 123I-serum amyloid P component in Alzheimer disease.

1 reference

12 December 2020

Amyloid probes based on Congo Red distinguish between fibrils comprising different peptides

1 reference

12 December 2020

In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease

1 reference

12 December 2020

Development of small molecule probes for the Beta-amyloid protein of Alzheimer's Disease

1 reference

12 December 2020

Chemical characterization of A beta 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease.

1 reference

12 December 2020

Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome

1 reference

12 December 2020

Alzheimer's amyloid fibrils: structure and assembly

1 reference

12 December 2020

Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates.

1 reference

12 December 2020

Deaths: final data for 1998.

1 reference

12 December 2020

Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain

1 reference

12 December 2020

Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline

1 reference

12 December 2020

Aggregation and disaggregation of senile plaques in Alzheimer disease

1 reference

12 December 2020

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

12 December 2020

X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology.

1 reference

12 December 2020

Secretases as targets for the treatment of Alzheimer's disease

1 reference

12 December 2020

10.1007/S00234-003-1034-9

Identifiers

DOI

1 reference

Dimensions Publication ID

27 June 2017

1023597144

0 references

1 reference